APDS
Clinical trials for APDS explained in plain language.
Never miss a new study
Get alerted when new APDS trials appear
Sign up with your email to follow new studies for APDS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Hope for tots with rare immune disease in new drug trial
Disease control OngoingThis study is testing a drug called leniolisib in very young children (ages 1 to 6) who have a rare genetic immune disorder called APDS. The goal is to see if the drug is safe and effective at controlling the disease by reducing swollen lymph nodes and infections. The children wi…
Matched conditions: APDS
Phase: PHASE3 • Sponsor: Pharming Technologies B.V. • Aim: Disease control
Last updated Apr 01, 2026 14:42 UTC
-
New hope for kids with rare immune disease
Disease control OngoingThis study is testing a medication called leniolisib in children aged 4 to 11 who have a rare genetic immune disorder called APDS. The main goals are to see if the drug is safe for children, how their bodies process it, and if it can help reduce swollen lymph nodes and infections…
Matched conditions: APDS
Phase: PHASE3 • Sponsor: Pharming Technologies B.V. • Aim: Disease control
Last updated Mar 30, 2026 14:34 UTC